{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:17:36Z","timestamp":1788419856408,"version":"build-2803163510"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"South African National Research Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Psoriasis is a chronic, immune-mediated inflammatory skin disease, affecting approximately 2% of the general population, which can be accompanied by psoriatic arthritis\u00a0(PsA). The condition has been associated with an increased cardiovascular burden. Hypercoagulability is a potential underlying mechanism that may contribute to the increased risk of major cardiovascular events in psoriatic individuals. Whole blood samples were collected from 20 PsA patients and 20 healthy individuals. The concentrations of inflammatory molecules (C-reactive protein, serum amyloid A, soluble intercellular adhesion molecule-1, soluble vascular cell adhesion molecule-1, and soluble P-selectin) were determined by enzyme-linked immunosorbent assays. In addition, clotting efficiency was evaluated by thromboelastography. The fibrin network architecture was also assessed by scanning electron microscopy. Elevated levels of circulating inflammatory molecules were significantly associated with the presence of psoriatic disease. Furthermore, an increased tendency towards thrombus formation was significantly predictive of disease presence. Scanning electron microscopy revealed that fibrin clots were denser in psoriatic individuals, compared to healthy controls, with an increased fibrin fibre diameter associated with psoriatic disease. Our results add to the accumulating evidence of the systemic nature of psoriasis and the subsequent risk of cardiovascular comorbidities, potentially due to an acquired hypercoagulability. We suggest that haemostatic function\u00a0should be monitored carefully in psoriatic patients that present with severe disease, due to the pre-eminent risk of developing thrombotic complications.<\/jats:p>","DOI":"10.1038\/s41598-021-90684-8","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T06:02:49Z","timestamp":1624341769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Psoriatic disease is associated with systemic inflammation, endothelial activation,\u00a0and altered haemostatic function"],"prefix":"10.1038","volume":"11","author":[{"given":"Maria J. E.","family":"Visser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantelle","family":"Venter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Tarr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9108-2384","authenticated-orcid":false,"given":"Etheresia","family":"Pretorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"key":"90684_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle, F. O., Kaplan, D. H. & Barker, J. Psoriasis. N. Engl. J. Med. 361, 496\u2013509. https:\/\/doi.org\/10.1056\/NEJMra0804595 (2009).","journal-title":"N. Engl. J. Med."},{"key":"90684_CR2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","volume":"69","author":"PJ Mease","year":"2013","unstructured":"Mease, P. J. et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics. J. Am. Acad. Dermatol. 69, 729\u2013735. https:\/\/doi.org\/10.1016\/j.jaad.2013.07.023 (2013).","journal-title":"J. Am. Acad. Dermatol."},{"key":"90684_CR3","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1155\/mi.2005.273","volume":"273\u2013279","author":"O Arican","year":"2005","unstructured":"Arican, O., Aral, M., Sasmaz, S. & Ciragil, P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediat. Inflamm. 273\u2013279, 2005. https:\/\/doi.org\/10.1155\/mi.2005.273 (2005).","journal-title":"Mediat. Inflamm."},{"key":"90684_CR4","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/jid.2010.340","volume":"131","author":"A Chiricozzi","year":"2011","unstructured":"Chiricozzi, A. et al. Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J. Invest. Dermatol. 131, 677\u2013687. https:\/\/doi.org\/10.1038\/jid.2010.340 (2011).","journal-title":"J. Invest. Dermatol."},{"key":"90684_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1084\/jem.20050500","volume":"202","author":"FO Nestle","year":"2005","unstructured":"Nestle, F. O. et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J. Exp. Med. 202, 135\u2013143. https:\/\/doi.org\/10.1084\/jem.20050500 (2005).","journal-title":"J. Exp. Med."},{"key":"90684_CR6","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J. Immunol. 182, 5836. https:\/\/doi.org\/10.4049\/jimmunol.0802999 (2009).","journal-title":"J. Immunol."},{"key":"90684_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00109-009-0457-0","volume":"87","author":"K Wolk","year":"2009","unstructured":"Wolk, K. et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J. Mol. Med. (Berlin) 87, 523\u2013536. https:\/\/doi.org\/10.1007\/s00109-009-0457-0 (2009).","journal-title":"J. Mol. Med. (Berlin)"},{"key":"90684_CR8","doi-asserted-by":"publisher","first-page":"e18125","DOI":"10.1371\/journal.pone.0018125","volume":"6","author":"O Ahlehoff","year":"2011","unstructured":"Ahlehoff, O. et al. Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study. PLoS ONE 6, e18125. https:\/\/doi.org\/10.1371\/journal.pone.0018125 (2011).","journal-title":"PLoS ONE"},{"key":"90684_CR9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1468-3083.2008.02636.x","volume":"22","author":"AD Cohen","year":"2008","unstructured":"Cohen, A. D. et al. Psoriasis and diabetes: a population-based cross-sectional study. J. Eur. Acad. Dermatol. Venereol. 22, 585\u2013589. https:\/\/doi.org\/10.1111\/j.1468-3083.2008.02636.x (2008).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"90684_CR10","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/bjd.14528","volume":"175","author":"A Egeberg","year":"2016","unstructured":"Egeberg, A. et al. Association between psoriasis and inflammatory bowel disease: a Danish nationwide cohort study. Br. J. Dermatol. 175, 487\u2013492. https:\/\/doi.org\/10.1111\/bjd.14528 (2016).","journal-title":"Br. J. Dermatol."},{"key":"90684_CR11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1001\/archdermatol.2010.186","volume":"146","author":"SK Kurd","year":"2010","unstructured":"Kurd, S. K., Troxel, A. B., Crits-Christoph, P. & Gelfand, J. M. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch. Dermatol. 146, 891\u2013895. https:\/\/doi.org\/10.1001\/archdermatol.2010.186 (2010).","journal-title":"Arch. Dermatol."},{"key":"90684_CR12","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/jid.2011.365","volume":"132","author":"SM Langan","year":"2012","unstructured":"Langan, S. M. et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J. Investig. Dermatol. 132, 556\u2013562. https:\/\/doi.org\/10.1038\/jid.2011.365 (2012).","journal-title":"J. Investig. Dermatol."},{"issue":"Suppl 3","key":"90684_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/jdv.12165","volume":"27","author":"C Pouplard","year":"2013","unstructured":"Pouplard, C. et al. Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies. J. Eur. Acad. Dermatol. Venereol.: JEADV 27(Suppl 3), 36\u201346. https:\/\/doi.org\/10.1111\/jdv.12165 (2013).","journal-title":"J. Eur. Acad. Dermatol. Venereol.: JEADV"},{"key":"90684_CR14","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/jid.2010.103","volume":"130","author":"BB Davidovici","year":"2010","unstructured":"Davidovici, B. B. et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J. Invest. Dermatol. 130, 1785\u20131796. https:\/\/doi.org\/10.1038\/jid.2010.103 (2010).","journal-title":"J. Invest. Dermatol."},{"key":"90684_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/bjd.12355","volume":"169","author":"EA Dowlatshahi","year":"2013","unstructured":"Dowlatshahi, E. A., van der Voort, E. A., Arends, L. R. & Nijsten, T. Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis. Br. J. Dermatol. 169, 266\u2013282. https:\/\/doi.org\/10.1111\/bjd.12355 (2013).","journal-title":"Br. J. Dermatol."},{"key":"90684_CR16","first-page":"210","volume":"33","author":"R Scarpa","year":"2006","unstructured":"Scarpa, R., Ayala, F., Caporaso, N. & Olivieri, I. Psoriasis, psoriatic arthritis, or psoriatic disease?. J. Rheumatol. 33, 210\u2013212 (2006).","journal-title":"J. Rheumatol."},{"key":"90684_CR17","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3899\/jrheum.190054","volume":"46","author":"E Lubrano","year":"2019","unstructured":"Lubrano, E., Scriffignano, S. & Perrotta, F. M. Psoriatic arthritis, psoriatic disease, or psoriatic syndrome?. J. Rheumatol. 46, 1428. https:\/\/doi.org\/10.3899\/jrheum.190054 (2019).","journal-title":"J. Rheumatol."},{"key":"90684_CR18","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1038\/jid.2009.112","volume":"129","author":"JM Gelfand","year":"2009","unstructured":"Gelfand, J. M. et al. The risk of stroke in patients with psoriasis. J. Invest. Dermatol. 129, 2411\u20132418. https:\/\/doi.org\/10.1038\/jid.2009.112 (2009).","journal-title":"J. Invest. Dermatol."},{"key":"90684_CR19","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","volume":"296","author":"JM Gelfand","year":"2006","unstructured":"Gelfand, J. M. et al. Risk of myocardial infarction in patients with psoriasis. JAMA 296, 1735\u20131741. https:\/\/doi.org\/10.1001\/jama.296.14.1735 (2006).","journal-title":"JAMA"},{"key":"90684_CR20","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/eurheartj\/ehp567","volume":"31","author":"NN Mehta","year":"2010","unstructured":"Mehta, N. N. et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur. Heart J. 31, 1000\u20131006. https:\/\/doi.org\/10.1093\/eurheartj\/ehp567 (2010).","journal-title":"Eur. Heart J."},{"key":"90684_CR21","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","volume":"74","author":"A Ogdie","year":"2015","unstructured":"Ogdie, A. et al. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann. Rheum. Dis. 74, 326\u2013332. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205675 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"90684_CR22","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/acr.22536","volume":"67","author":"FC Ernste","year":"2015","unstructured":"Ernste, F. C. et al. Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study. Arthritis Care Res. (Hoboken) 67, 1015\u20131021. https:\/\/doi.org\/10.1002\/acr.22536 (2015).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"90684_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2017","unstructured":"Agca, R. et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann. Rheum. Dis. 76, 17\u201328. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209775 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"90684_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1039\/c4ib00173g","volume":"7","author":"DB Kell","year":"2015","unstructured":"Kell, D. B. & Pretorius, E. The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen). Integr. Biol.: Quant. Biosci Nano Macro 7, 24\u201352. https:\/\/doi.org\/10.1039\/c4ib00173g (2015).","journal-title":"Integr. Biol.: Quant. Biosci Nano Macro"},{"key":"90684_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/01.CIR.0000085568.13915.1E","volume":"108","author":"HD Danenberg","year":"2003","unstructured":"Danenberg, H. D. et al. Increased thrombosis after arterial injury in human C-reactive protein\u2013transgenic mice. Circulation 108, 512\u2013515. https:\/\/doi.org\/10.1161\/01.CIR.0000085568.13915.1E (2003).","journal-title":"Circulation"},{"key":"90684_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/s0049-3848(00)00356-x","volume":"100","author":"H Tohgi","year":"2000","unstructured":"Tohgi, H. et al. Activated coagulation\/fibrinolysis system and platelet function in acute thrombotic stroke patients with increased C-reactive protein levels. Thromb. Res. 100, 373\u2013379. https:\/\/doi.org\/10.1016\/s0049-3848(00)00356-x (2000).","journal-title":"Thromb. Res."},{"key":"90684_CR27","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1160\/th09-04-0274","volume":"102","author":"AR Folsom","year":"2009","unstructured":"Folsom, A. R., Lutsey, P. L., Astor, B. C. & Cushman, M. C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort. Thromb. Haemost. 102, 615\u2013619. https:\/\/doi.org\/10.1160\/th09-04-0274 (2009).","journal-title":"Thromb. Haemost."},{"key":"90684_CR28","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","volume":"109","author":"M Levi","year":"2004","unstructured":"Levi, M., Poll, T. V. D. & B\u00fcller, H. R. Bidirectional relation between inflammation and coagulation. Circulation 109, 2698\u20132704. https:\/\/doi.org\/10.1161\/01.CIR.0000131660.51520.9A (2004).","journal-title":"Circulation"},{"key":"90684_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.11613\/BM.2012.006","volume":"22","author":"S Margetic","year":"2012","unstructured":"Margetic, S. Inflammation and haemostasis. Biochem. Med. 22, 49\u201362 (2012).","journal-title":"Biochem. Med."},{"key":"90684_CR30","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1161\/atvbaha.110.213389","volume":"31","author":"ST Lord","year":"2011","unstructured":"Lord, S. T. Molecular mechanisms affecting fibrin structure and stability. Arterioscler. Thromb. Vasc. Biol. 31, 494\u2013499. https:\/\/doi.org\/10.1161\/atvbaha.110.213389 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"90684_CR31","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1161\/01.ATV.0000241589.52950.4c","volume":"26","author":"JP Collet","year":"2006","unstructured":"Collet, J. P. et al. Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis. Arterioscler. Thromb. Vasc. Biol. 26, 2567\u20132573. https:\/\/doi.org\/10.1161\/01.ATV.0000241589.52950.4c (2006).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"90684_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.thromres.2010.09.011","volume":"127","author":"E Rooth","year":"2011","unstructured":"Rooth, E., Wallen, N. H., Blomb\u00e4ck, M. & He, S. Decreased fibrin network permeability and impaired fibrinolysis in the acute and convalescent phase of ischemic stroke. Thromb. Res. 127, 51\u201356. https:\/\/doi.org\/10.1016\/j.thromres.2010.09.011 (2011).","journal-title":"Thromb. Res."},{"key":"90684_CR33","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.1182\/blood-2009-05-222380","volume":"114","author":"A Undas","year":"2009","unstructured":"Undas, A. et al. Altered fibrin clot structure\/function in patients with idiopathic venous thromboembolism and in their relatives. Blood 114, 4272\u20134278. https:\/\/doi.org\/10.1182\/blood-2009-05-222380 (2009).","journal-title":"Blood"},{"key":"90684_CR34","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1172\/jci22782","volume":"115","author":"K Abeyama","year":"2005","unstructured":"Abeyama, K. et al. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J. Clin. Investig. 115, 1267\u20131274. https:\/\/doi.org\/10.1172\/jci22782 (2005).","journal-title":"J. Clin. Investig."},{"key":"90684_CR35","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1182\/blood-2004-06-2456","volume":"105","author":"T Iwaki","year":"2005","unstructured":"Iwaki, T., Cruz, D. T., Martin, J. A. & Castellino, F. J. A cardioprotective role for the endothelial protein C receptor in lipopolysaccharide-induced endotoxemia in the mouse. Blood 105, 2364\u20132371. https:\/\/doi.org\/10.1182\/blood-2004-06-2456 (2005).","journal-title":"Blood"},{"key":"90684_CR36","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1073\/pnas.83.12.4533","volume":"83","author":"MP Bevilacqua","year":"1986","unstructured":"Bevilacqua, M. P. et al. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc. Natl. Acad. Sci. U.S.A. 83, 4533\u20134537. https:\/\/doi.org\/10.1073\/pnas.83.12.4533 (1986).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"90684_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/01.RES.0000252802.25497.b7","volume":"100","author":"P von Hundelshausen","year":"2007","unstructured":"von Hundelshausen, P. & Weber, C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ. Res. 100, 27\u201340. https:\/\/doi.org\/10.1161\/01.RES.0000252802.25497.b7 (2007).","journal-title":"Circ. Res."},{"key":"90684_CR38","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.1182\/blood-2008-01-078204","volume":"111","author":"DD Wagner","year":"2008","unstructured":"Wagner, D. D. & Frenette, P. S. The vessel wall and its interactions. Blood 111, 5271\u20135281. https:\/\/doi.org\/10.1182\/blood-2008-01-078204 (2008).","journal-title":"Blood"},{"key":"90684_CR39","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.1073\/pnas.92.16.7450","volume":"92","author":"PS Frenette","year":"1995","unstructured":"Frenette, P. S., Johnson, R. C., Hynes, R. O. & Wagner, D. D. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc. Natl. Acad. Sci. U. S. A. 92, 7450\u20137454. https:\/\/doi.org\/10.1073\/pnas.92.16.7450 (1995).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"90684_CR40","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1177\/0003319717732238","volume":"69","author":"P Poredos","year":"2017","unstructured":"Poredos, P. & Jezovnik, M. K. Endothelial dysfunction and venous thrombosis. Angiology 69, 564\u2013567. https:\/\/doi.org\/10.1177\/0003319717732238 (2017).","journal-title":"Angiology"},{"key":"90684_CR41","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/eurheartj\/ehw550","volume":"38","author":"M Koupenova","year":"2017","unstructured":"Koupenova, M., Kehrel, B. E., Corkrey, H. A. & Freedman, J. E. Thrombosis and platelets: an update. Eur. Heart J. 38, 785\u2013791. https:\/\/doi.org\/10.1093\/eurheartj\/ehw550 (2017).","journal-title":"Eur. Heart J."},{"key":"90684_CR42","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.clindermatol.2013.11.001","volume":"32","author":"I Grozdev","year":"2014","unstructured":"Grozdev, I., Korman, N. & Tsankov, N. Psoriasis as a systemic disease. Clin. Dermatol. 32, 343\u2013350. https:\/\/doi.org\/10.1016\/j.clindermatol.2013.11.001 (2014).","journal-title":"Clin. Dermatol."},{"key":"90684_CR43","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/bjd.18245","volume":"182","author":"NJ Korman","year":"2020","unstructured":"Korman, N. J. Management of psoriasis as a systemic disease: what is the evidence?. Br. J. Dermatol. 182, 840\u2013848. https:\/\/doi.org\/10.1111\/bjd.18245 (2020).","journal-title":"Br. J. Dermatol."},{"key":"90684_CR44","doi-asserted-by":"publisher","first-page":"6367","DOI":"10.1073\/pnas.86.16.6367","volume":"86","author":"RM Grossman","year":"1989","unstructured":"Grossman, R. M. et al. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc. Natl. Acad. Sci. U. S. A. 86, 6367\u20136371. https:\/\/doi.org\/10.1073\/pnas.86.16.6367 (1989).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"90684_CR45","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1136\/ard.2005.050963","volume":"65","author":"AWR van Kuijk","year":"2006","unstructured":"van Kuijk, A. W. R., Reinders-Blankert, P., Smeets T. J. M., Dijkmans, B. A. C. & Tak, P. P. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann. Rheum. Dis. 65(12), 1551\u20131557. https:\/\/doi.org\/10.1136\/ard.2005.050963 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"90684_CR46","doi-asserted-by":"publisher","first-page":"e0181486","DOI":"10.1371\/journal.pone.0181486","volume":"12","author":"E Couderc","year":"2017","unstructured":"Couderc, E. et al. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis. PLoS ONE 12, e0181486. https:\/\/doi.org\/10.1371\/journal.pone.0181486 (2017).","journal-title":"PLoS ONE"},{"issue":"6","key":"90684_CR47","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/art.20301","volume":"50","author":"R O'Hara","year":"2004","unstructured":"O'Hara, R., Murphy, E. P., , Whitehead, A. S., FitzGerald, O. & Bresnihan, B. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis. Arthritis Rheum. 50(6), 1788\u20131799. https:\/\/doi.org\/10.1002\/art.20301 (2004).","journal-title":"Arthritis Rheum."},{"key":"90684_CR48","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1161\/01.ATV.0000183718.62409.ea","volume":"25","author":"U Singh","year":"2005","unstructured":"Singh, U., Devaraj, S. & Jialal, I. C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells. Arterioscler. Thromb. Vasc. Biol. 25, 2216\u20132221. https:\/\/doi.org\/10.1161\/01.ATV.0000183718.62409.ea (2005).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"90684_CR49","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1182\/blood.V82.2.513.513","volume":"82","author":"J Cermak","year":"1993","unstructured":"Cermak, J. et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82, 513\u2013520 (1993).","journal-title":"Blood"},{"key":"90684_CR50","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.4049\/jimmunol.178.3.1852","volume":"178","author":"H Cai","year":"2007","unstructured":"Cai, H. et al. Serum amyloid A induces monocyte tissue factor. J. Immunol. 178, 1852\u20131860. https:\/\/doi.org\/10.4049\/jimmunol.178.3.1852 (2007).","journal-title":"J. Immunol."},{"key":"90684_CR51","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1161\/atvbaha.106.137455","volume":"27","author":"Y Zhao","year":"2007","unstructured":"Zhao, Y., Zhou, S. & Heng, C. K. Impact of serum amyloid A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 27, 1645\u20131650. https:\/\/doi.org\/10.1161\/atvbaha.106.137455 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"90684_CR52","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1016\/j.febslet.2009.07.037","volume":"583","author":"Y Chen","year":"2009","unstructured":"Chen, Y. et al. CRP regulates the expression and activity of tissue factor as well as tissue factor pathway inhibitor via NF-kappaB and ERK 1\/2 MAPK pathway. FEBS Lett. 583, 2811\u20132818. https:\/\/doi.org\/10.1016\/j.febslet.2009.07.037 (2009).","journal-title":"FEBS Lett."},{"key":"90684_CR53","doi-asserted-by":"publisher","first-page":"946509","DOI":"10.1155\/2015\/946509","volume":"2015","author":"M Schnoor","year":"2015","unstructured":"Schnoor, M., Alcaide, P., Voisin, M. B. & van Buul, J. D. Crossing the vascular wall: common and unique mechanisms exploited by different leukocyte subsets during extravasation. Mediat. Inflamm. 2015, 946509. https:\/\/doi.org\/10.1155\/2015\/946509 (2015).","journal-title":"Mediat. Inflamm."},{"key":"90684_CR54","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/labinvest.3780242","volume":"81","author":"JB Rottman","year":"2001","unstructured":"Rottman, J. B., Smith, T. L., Ganley, K. G., Kikuchi, T. & Krueger, J. G. Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris. Lab. Investig. J. Tech. Methods Pathol. 81, 335\u2013347. https:\/\/doi.org\/10.1038\/labinvest.3780242 (2001).","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"90684_CR55","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1084\/jem.187.3.329","volume":"187","author":"T Bombeli","year":"1998","unstructured":"Bombeli, T., Schwartz, B. R. & Harlan, J. M. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J. Exp. Med. 187, 329\u2013339. https:\/\/doi.org\/10.1084\/jem.187.3.329 (1998).","journal-title":"J. Exp. Med."},{"key":"90684_CR56","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/s1050-1738(01)00157-8","volume":"12","author":"NL Tsakadze","year":"2002","unstructured":"Tsakadze, N. L., Zhao, Z. & D\u2019Souza, S. E. Interactions of intercellular adhesion molecule-1 with fibrinogen. Trends Cardiovasc. Med. 12, 101\u2013108. https:\/\/doi.org\/10.1016\/s1050-1738(01)00157-8 (2002).","journal-title":"Trends Cardiovasc. Med."},{"key":"90684_CR57","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/00004311-200101000-00005","volume":"39","author":"V Srinivasa","year":"2001","unstructured":"Srinivasa, V., Gilbertson, L. I. & Bhavani-Shankar, K. Thromboelastography: where is it and where is it heading?. Int. Anesthesiol. Clin. 39, 35\u201349. https:\/\/doi.org\/10.1097\/00004311-200101000-00005 (2001).","journal-title":"Int. Anesthesiol. Clin."},{"key":"90684_CR58","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1684\/ejd.2012.1714","volume":"22","author":"S Arias-Santiago","year":"2012","unstructured":"Arias-Santiago, S. et al. Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis. Eur. J. Dermatol. 22, 337\u2013344. https:\/\/doi.org\/10.1684\/ejd.2012.1714 (2012).","journal-title":"Eur. J. Dermatol."},{"key":"90684_CR59","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/j.1365-2133.2004.05984.x","volume":"150","author":"P Rocha-Pereira","year":"2004","unstructured":"Rocha-Pereira, P. et al. The inflammatory response in mild and in severe psoriasis. Br. J. Dermatol. 150, 917\u2013928. https:\/\/doi.org\/10.1111\/j.1365-2133.2004.05984.x (2004).","journal-title":"Br. J. Dermatol."},{"key":"90684_CR60","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.semarthrit.2006.09.001","volume":"36","author":"O Kimhi","year":"2007","unstructured":"Kimhi, O. et al. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin. Arthritis Rheum. 36, 203\u2013209. https:\/\/doi.org\/10.1016\/j.semarthrit.2006.09.001 (2007).","journal-title":"Semin. Arthritis Rheum."},{"key":"90684_CR61","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1161\/01.atv.17.12.3399","volume":"17","author":"FJ Neumann","year":"1997","unstructured":"Neumann, F. J. et al. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler. Thromb. Vasc. Biol. 17, 3399\u20133405. https:\/\/doi.org\/10.1161\/01.atv.17.12.3399 (1997).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"90684_CR62","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/annrheumdis-2011-200468","volume":"71","author":"A Hot","year":"2012","unstructured":"Hot, A., Lenief, V. & Miossec, P. Combination of IL-17 and TNFalpha induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells. Ann. Rheum. Dis. 71, 768\u2013776. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200468 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"90684_CR63","doi-asserted-by":"publisher","first-page":"e0127558","DOI":"10.1371\/journal.pone.0127558","volume":"10","author":"M Paul","year":"2015","unstructured":"Paul, M. et al. Methotrexate promotes platelet apoptosis via JNK-mediated mitochondrial damage: alleviation by N-acetylcysteine and N-acetylcysteine amide. PLoS ONE 10, e0127558. https:\/\/doi.org\/10.1371\/journal.pone.0127558 (2015).","journal-title":"PLoS ONE"},{"key":"90684_CR64","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10067-009-1323-8","volume":"29","author":"F Canpolat","year":"2009","unstructured":"Canpolat, F., Akpinar, H. & Eskio\u011flu, F. Mean platelet volume in psoriasis and psoriatic arthritis. Clin. Rheumatol. 29, 325\u2013328. https:\/\/doi.org\/10.1007\/s10067-009-1323-8 (2009).","journal-title":"Clin. Rheumatol."},{"key":"90684_CR65","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jaad.2009.06.053","volume":"62","author":"R Tamagawa-Mineoka","year":"2010","unstructured":"Tamagawa-Mineoka, R., Katoh, N. & Kishimoto, S. Platelet activation in patients with psoriasis: increased plasma levels of platelet-derived microparticles and soluble P-selectin. J. Am. Acad. Dermatol. 62, 621\u2013626. https:\/\/doi.org\/10.1016\/j.jaad.2009.06.053 (2010).","journal-title":"J. Am. Acad. Dermatol."},{"key":"90684_CR66","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10067-009-1323-8","volume":"29","author":"F Canpolat","year":"2010","unstructured":"Canpolat, F., Akpinar, H. & Eskio\u011flu, F. Mean platelet volume in psoriasis and psoriatic arthritis. Clin. Rheumatol. 29, 325\u2013328. https:\/\/doi.org\/10.1007\/s10067-009-1323-8 (2010).","journal-title":"Clin. Rheumatol."},{"key":"90684_CR67","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1161\/ATVBAHA.116.308622","volume":"37","author":"V Tutwiler","year":"2017","unstructured":"Tutwiler, V. et al. Contraction of blood clots is impaired in acute ischemic stroke. Arterioscler. Thromb. Vasc. Biol. 37, 271\u2013279. https:\/\/doi.org\/10.1161\/ATVBAHA.116.308622 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"90684_CR68","doi-asserted-by":"publisher","first-page":"eabc0496","DOI":"10.1126\/sciadv.abc0496","volume":"6","author":"V Tutwiler","year":"2020","unstructured":"Tutwiler, V. et al. Rupture of blood clots: mechanics and pathophysiology. Sci. Adv. 6, eabc0496. https:\/\/doi.org\/10.1126\/sciadv.abc0496 (2020).","journal-title":"Sci. Adv."},{"key":"90684_CR69","doi-asserted-by":"publisher","first-page":"873","DOI":"10.20452\/pamw.4165","volume":"127","author":"M Z\u0105bczyk","year":"2017","unstructured":"Z\u0105bczyk, M. & Undas, A. Plasma fibrin clot structure and thromboembolism: clinical implications. Pol. Arch. Intern. Med. 127, 873\u2013881. https:\/\/doi.org\/10.20452\/pamw.4165 (2017).","journal-title":"Pol. Arch. Intern. Med."},{"key":"90684_CR70","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.blre.2006.11.001","volume":"21","author":"AS Wolberg","year":"2007","unstructured":"Wolberg, A. S. Thrombin generation and fibrin clot structure. Blood Rev. 21, 131\u2013142. https:\/\/doi.org\/10.1016\/j.blre.2006.11.001 (2007).","journal-title":"Blood Rev."},{"key":"90684_CR71","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1160\/th14-08-0669","volume":"113","author":"I Varj\u00fa","year":"2015","unstructured":"Varj\u00fa, I. et al. DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment. Thromb. Haemost. 113, 1289\u20131298. https:\/\/doi.org\/10.1160\/th14-08-0669 (2015).","journal-title":"Thromb. Haemost."},{"key":"90684_CR72","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1161\/ATVBAHA.114.303785","volume":"34","author":"M Becatti","year":"2014","unstructured":"Becatti, M. et al. Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 34, 1355\u20131361. https:\/\/doi.org\/10.1161\/ATVBAHA.114.303785 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"90684_CR73","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/s0735-1097(99)00007-8","volume":"33","author":"J Ma","year":"1999","unstructured":"Ma, J., Hennekens, C. H., Ridker, P. M. & Stampfer, M. J. A prospective study of fibrinogen and risk of myocardial infarction in the Physicians\u2019 Health Study. J. Am. Coll. Cardiol. 33, 1347\u20131352. https:\/\/doi.org\/10.1016\/s0735-1097(99)00007-8 (1999).","journal-title":"J. Am. Coll. Cardiol."},{"key":"90684_CR74","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1111\/jth.13043","volume":"13","author":"A van Hylckama Vlieg","year":"2015","unstructured":"van Hylckama Vlieg, A. et al. The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study. J. Thromb. Haemost. 13, 1642\u20131652. https:\/\/doi.org\/10.1111\/jth.13043 (2015).","journal-title":"J. Thromb. Haemost."},{"key":"90684_CR75","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor, W. et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 54, 2665\u20132673. https:\/\/doi.org\/10.1002\/art.21972 (2006).","journal-title":"Arthritis Rheum."},{"key":"90684_CR76","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1213\/01.Ane.0000136843.58799.Ab","volume":"99","author":"VG Nielsen","year":"2004","unstructured":"Nielsen, V. G., Lyerly, R. T. 3rd. & Gurley, W. Q. The effect of dilution on plasma coagulation kinetics determined by thrombelastography is dependent on antithrombin activity and mode of activation. Anesth. Analg. 99, 1587\u20131592. https:\/\/doi.org\/10.1213\/01.Ane.0000136843.58799.Ab (2004).","journal-title":"Anesth. Analg."},{"key":"90684_CR77","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cca.2014.05.013","volume":"436","author":"BS Karon","year":"2014","unstructured":"Karon, B. S. Why is everyone so excited about thromboelastrography (TEG)?. Clin. Chim. Acta; Int. J. Clin. Chem. 436, 143\u2013148. https:\/\/doi.org\/10.1016\/j.cca.2014.05.013 (2014).","journal-title":"Clin. Chim. Acta; Int. J. Clin. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90684-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90684-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90684-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T05:21:25Z","timestamp":1670044885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90684-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["90684"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-90684-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"assertion":[{"value":"22 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13043"}}